Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.40037530 |
2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.40037530 |
3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.25244060 |
4 | COPI coating of Golgi vesicle (GO:0048205) | 4.04476756 |
5 | Golgi transport vesicle coating (GO:0048200) | 4.04476756 |
6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.91053538 |
7 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.83688821 |
8 | regulation of cholesterol homeostasis (GO:2000188) | 3.57952017 |
9 | regulation of gamma-delta T cell activation (GO:0046643) | 3.56368298 |
10 | response to muramyl dipeptide (GO:0032495) | 3.54832353 |
11 | response to peptidoglycan (GO:0032494) | 3.49921988 |
12 | NIK/NF-kappaB signaling (GO:0038061) | 3.48793847 |
13 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.47442098 |
14 | positive regulation of histone deacetylation (GO:0031065) | 3.45515534 |
15 | detection of bacterium (GO:0016045) | 3.43661015 |
16 | detection of other organism (GO:0098543) | 3.42145419 |
17 | negative regulation of cell killing (GO:0031342) | 3.33197851 |
18 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.33197851 |
19 | germinal center formation (GO:0002467) | 3.29593546 |
20 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.14278202 |
21 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.10548302 |
22 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.09422634 |
23 | leukocyte aggregation (GO:0070486) | 3.02340023 |
24 | low-density lipoprotein particle clearance (GO:0034383) | 3.01736617 |
25 | immunoglobulin mediated immune response (GO:0016064) | 3.00395703 |
26 | positive thymic T cell selection (GO:0045059) | 2.99720707 |
27 | negative regulation of interleukin-12 production (GO:0032695) | 2.97259753 |
28 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.92016139 |
29 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.89868552 |
30 | regulation of cholesterol storage (GO:0010885) | 2.89668692 |
31 | hepatocyte apoptotic process (GO:0097284) | 2.89557672 |
32 | detection of external biotic stimulus (GO:0098581) | 2.88545805 |
33 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.88389742 |
34 | apoptotic cell clearance (GO:0043277) | 2.88004150 |
35 | mannose metabolic process (GO:0006013) | 2.87933422 |
36 | regulation of leukocyte degranulation (GO:0043300) | 2.85785083 |
37 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.85005997 |
38 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.83353921 |
39 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.82805389 |
40 | response to type I interferon (GO:0034340) | 2.82058921 |
41 | positive regulation of nuclease activity (GO:0032075) | 2.81196122 |
42 | neutrophil activation involved in immune response (GO:0002283) | 2.80304915 |
43 | type I interferon signaling pathway (GO:0060337) | 2.78554866 |
44 | cellular response to type I interferon (GO:0071357) | 2.78554866 |
45 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.76781239 |
46 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.73660941 |
47 | growth hormone receptor signaling pathway (GO:0060396) | 2.72270956 |
48 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.71615800 |
49 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.69954329 |
50 | pentose-phosphate shunt (GO:0006098) | 2.69772388 |
51 | negative regulation of cell size (GO:0045792) | 2.69462412 |
52 | protein localization to endosome (GO:0036010) | 2.69272965 |
53 | negative thymic T cell selection (GO:0045060) | 2.67248579 |
54 | alpha-linolenic acid metabolic process (GO:0036109) | 2.66443072 |
55 | regulation of mast cell degranulation (GO:0043304) | 2.64918191 |
56 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.64878657 |
57 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.64434488 |
58 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.64278253 |
59 | cellular extravasation (GO:0045123) | 2.61982045 |
60 | negative T cell selection (GO:0043383) | 2.60313634 |
61 | positive regulation by symbiont of host defense response (GO:0052509) | 2.58796856 |
62 | modulation by symbiont of host defense response (GO:0052031) | 2.58796856 |
63 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.58796856 |
64 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.58796856 |
65 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.58796856 |
66 | modulation by symbiont of host immune response (GO:0052553) | 2.58796856 |
67 | regulation of nuclease activity (GO:0032069) | 2.57922641 |
68 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.56535551 |
69 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.54873665 |
70 | receptor catabolic process (GO:0032801) | 2.53088331 |
71 | natural killer cell differentiation (GO:0001779) | 2.53051763 |
72 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.53002064 |
73 | regulation of necroptotic process (GO:0060544) | 2.52430637 |
74 | thymic T cell selection (GO:0045061) | 2.52192904 |
75 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.51666999 |
76 | detection of biotic stimulus (GO:0009595) | 2.51400361 |
77 | negative regulation of granulocyte differentiation (GO:0030853) | 2.50673830 |
78 | detection of molecule of bacterial origin (GO:0032490) | 2.49580442 |
79 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.49572868 |
80 | positive regulation of lamellipodium assembly (GO:0010592) | 2.49566784 |
81 | histone H3-K36 demethylation (GO:0070544) | 2.48229048 |
82 | vesicle coating (GO:0006901) | 2.48207261 |
83 | COPII vesicle coating (GO:0048208) | 2.48173772 |
84 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.47400969 |
85 | phospholipid homeostasis (GO:0055091) | 2.46866447 |
86 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.45815857 |
87 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.45501298 |
88 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.44300362 |
89 | positive regulation of protein deacetylation (GO:0090312) | 2.44098338 |
90 | barbed-end actin filament capping (GO:0051016) | 2.43604546 |
91 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.43501574 |
92 | myeloid dendritic cell differentiation (GO:0043011) | 2.42951078 |
93 | modulation by symbiont of host cellular process (GO:0044068) | 2.42840619 |
94 | positive regulation of p38MAPK cascade (GO:1900745) | 2.42145721 |
95 | response to host immune response (GO:0052572) | 2.40916129 |
96 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.40916129 |
97 | response to host (GO:0075136) | 2.40819441 |
98 | response to host defenses (GO:0052200) | 2.40819441 |
99 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.40819441 |
100 | regulation of extracellular matrix disassembly (GO:0010715) | 2.38923928 |
101 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.38836730 |
102 | signal complex assembly (GO:0007172) | 2.38621866 |
103 | tolerance induction (GO:0002507) | 2.38490188 |
104 | macrophage activation involved in immune response (GO:0002281) | 2.38460516 |
105 | NADPH regeneration (GO:0006740) | 2.37227598 |
106 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.37135294 |
107 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.36635328 |
108 | intestinal cholesterol absorption (GO:0030299) | 2.36135121 |
109 | embryonic process involved in female pregnancy (GO:0060136) | 2.35521736 |
110 | regulation of T cell tolerance induction (GO:0002664) | 2.35211222 |
111 | negative regulation of innate immune response (GO:0045824) | 2.34908853 |
112 | positive regulation of Rap GTPase activity (GO:0032854) | 2.34763786 |
113 | regulation of regulated secretory pathway (GO:1903305) | 2.34707148 |
114 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.34581771 |
115 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.33987650 |
116 | regulation of translational fidelity (GO:0006450) | 2.33495330 |
117 | negative regulation of myotube differentiation (GO:0010832) | 2.33177276 |
118 | cellular response to unfolded protein (GO:0034620) | 2.32860056 |
119 | cellular response to growth hormone stimulus (GO:0071378) | 2.32395360 |
120 | positive regulation of B cell differentiation (GO:0045579) | 2.32246259 |
121 | regulation of defense response to virus by virus (GO:0050690) | 2.31924744 |
122 | T cell migration (GO:0072678) | 2.31624655 |
123 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.31402616 |
124 | negative regulation of lipid transport (GO:0032369) | 2.30361614 |
125 | defense response to protozoan (GO:0042832) | 2.29666012 |
126 | ER-nucleus signaling pathway (GO:0006984) | 2.28800174 |
127 | sodium ion export (GO:0071436) | 2.28423803 |
128 | myeloid cell activation involved in immune response (GO:0002275) | 2.28256285 |
129 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.28242478 |
130 | regulation of antigen processing and presentation (GO:0002577) | 2.28066379 |
131 | maternal placenta development (GO:0001893) | 2.25655038 |
132 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.25623798 |
133 | regulation of tolerance induction (GO:0002643) | 2.25534285 |
134 | response to protozoan (GO:0001562) | 2.25368979 |
135 | positive regulation of lamellipodium organization (GO:1902745) | 2.25208037 |
136 | positive regulation of antigen processing and presentation (GO:0002579) | 2.24736278 |
137 | macroautophagy (GO:0016236) | 2.24596478 |
138 | response to laminar fluid shear stress (GO:0034616) | 2.24553110 |
139 | protein-lipid complex assembly (GO:0065005) | 2.24305088 |
140 | cell adhesion mediated by integrin (GO:0033627) | 2.23633323 |
141 | positive regulation of interferon-alpha production (GO:0032727) | 2.21339151 |
142 | urea cycle (GO:0000050) | 2.20679977 |
143 | urea metabolic process (GO:0019627) | 2.20679977 |
144 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.20565421 |
145 | regulation of ARF protein signal transduction (GO:0032012) | 2.19439825 |
146 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.19269602 |
147 | negative regulation of sterol transport (GO:0032372) | 2.19035589 |
148 | negative regulation of cholesterol transport (GO:0032375) | 2.19035589 |
149 | regulation of translational termination (GO:0006449) | 2.18885659 |
150 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.17506871 |
151 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.17504878 |
152 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.16166732 |
153 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.16032239 |
154 | leukocyte cell-cell adhesion (GO:0007159) | 2.15380090 |
155 | valine metabolic process (GO:0006573) | 2.14597924 |
156 | intestinal absorption (GO:0050892) | 2.12921351 |
157 | T cell selection (GO:0045058) | 2.11902817 |
158 | regulation of ARF GTPase activity (GO:0032312) | 2.11770571 |
159 | B cell receptor signaling pathway (GO:0050853) | 2.11646853 |
160 | regulation of response to interferon-gamma (GO:0060330) | 2.10606611 |
161 | cellular response to topologically incorrect protein (GO:0035967) | 2.09657996 |
162 | positive T cell selection (GO:0043368) | 2.09289420 |
163 | NLS-bearing protein import into nucleus (GO:0006607) | 2.08994395 |
164 | lipoprotein transport (GO:0042953) | 2.08788808 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.94407427 |
2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.54826755 |
3 | MYC_22102868_ChIP-Seq_BL_Human | 3.09189119 |
4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.92769054 |
5 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.89181210 |
6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.73550815 |
7 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.40933202 |
8 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.29657448 |
9 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.28577483 |
10 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.27404263 |
11 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.20304038 |
12 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.19713422 |
13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.19401259 |
14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.13106097 |
15 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.11306184 |
16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.07790104 |
17 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.06245880 |
18 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.02658931 |
19 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.01973852 |
20 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.00256551 |
21 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.95057809 |
22 | MAF_26560356_Chip-Seq_TH1_Human | 1.94564908 |
23 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.94391897 |
24 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.92781783 |
25 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.90044129 |
26 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.88105164 |
27 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.87538685 |
28 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.86510585 |
29 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.81295602 |
30 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.79865085 |
31 | UTX_26944678_Chip-Seq_JUKART_Human | 1.79768437 |
32 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.77188356 |
33 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.76815695 |
34 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.75256992 |
35 | GATA1_22025678_ChIP-Seq_K562_Human | 1.74802747 |
36 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.71965347 |
37 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.67136098 |
38 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.66201387 |
39 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.65664000 |
40 | SPI1_23127762_ChIP-Seq_K562_Human | 1.65388228 |
41 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.64976581 |
42 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.61941111 |
43 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.60538918 |
44 | MYB_26560356_Chip-Seq_TH2_Human | 1.60316564 |
45 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.58505428 |
46 | MYB_26560356_Chip-Seq_TH1_Human | 1.57484916 |
47 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.57024546 |
48 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.55705682 |
49 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.53403154 |
50 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.49932180 |
51 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.44793341 |
52 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.44685230 |
53 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.44640168 |
54 | P68_20966046_ChIP-Seq_HELA_Human | 1.43882161 |
55 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.43028304 |
56 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.42131246 |
57 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.41927129 |
58 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41777674 |
59 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.41689089 |
60 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.41544759 |
61 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.41268736 |
62 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.37680620 |
63 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.36537631 |
64 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.36135633 |
65 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.35557862 |
66 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.34683254 |
67 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.33812315 |
68 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.33278844 |
69 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.33046720 |
70 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32089487 |
71 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.30028263 |
72 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.29191801 |
73 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.28911482 |
74 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.28781670 |
75 | ATF3_27146783_Chip-Seq_COLON_Human | 1.27956061 |
76 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.27677925 |
77 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.26829398 |
78 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.23049956 |
79 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.21830592 |
80 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.20111217 |
81 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.19480468 |
82 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.19294478 |
83 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.18891405 |
84 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.18845898 |
85 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.18666882 |
86 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.18199452 |
87 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.17920930 |
88 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.17316375 |
89 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.16878318 |
90 | GATA1_19941826_ChIP-Seq_K562_Human | 1.16737184 |
91 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.16672012 |
92 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.16357086 |
93 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.15436526 |
94 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.14527917 |
95 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.14472488 |
96 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.14412404 |
97 | * MAF_26560356_Chip-Seq_TH2_Human | 1.14015871 |
98 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.13779082 |
99 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13358378 |
100 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12455407 |
101 | KDM2B_26808549_Chip-Seq_K562_Human | 1.10816225 |
102 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.10472028 |
103 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.09014529 |
104 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.08801353 |
105 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.07703636 |
106 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.07139014 |
107 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.05645339 |
108 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05526405 |
109 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.04700927 |
110 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.04550800 |
111 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03952300 |
112 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.03399407 |
113 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.03260661 |
114 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.02239235 |
115 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.01863809 |
116 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.01124311 |
117 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.00808741 |
118 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.00778495 |
119 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00128551 |
120 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.00061764 |
121 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.99444359 |
122 | GATA2_19941826_ChIP-Seq_K562_Human | 0.97331729 |
123 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.97199427 |
124 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.96001659 |
125 | * MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.95965339 |
126 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.95878028 |
127 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.95855053 |
128 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.95315755 |
129 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.95197947 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003300_gastrointestinal_ulcer | 3.30596436 |
2 | MP0003705_abnormal_hypodermis_morpholog | 3.03745528 |
3 | MP0010234_abnormal_vibrissa_follicle | 2.79641299 |
4 | MP0005360_urolithiasis | 2.74623089 |
5 | MP0000569_abnormal_digit_pigmentation | 2.73531304 |
6 | MP0009840_abnormal_foam_cell | 2.63501111 |
7 | MP0010352_gastrointestinal_tract_polyps | 2.54003902 |
8 | MP0005451_abnormal_body_composition | 2.44973604 |
9 | MP0003303_peritoneal_inflammation | 2.42703585 |
10 | MP0003724_increased_susceptibility_to | 2.36329687 |
11 | MP0008260_abnormal_autophagy | 2.27130136 |
12 | MP0003172_abnormal_lysosome_physiology | 2.13912652 |
13 | MP0005076_abnormal_cell_differentiation | 2.13163067 |
14 | MP0003436_decreased_susceptibility_to | 2.12148522 |
15 | MP0003183_abnormal_peptide_metabolism | 2.06090183 |
16 | MP0005058_abnormal_lysosome_morphology | 2.04058638 |
17 | MP0004947_skin_inflammation | 2.01924395 |
18 | MP0002139_abnormal_hepatobiliary_system | 1.97095526 |
19 | MP0005365_abnormal_bile_salt | 1.95224654 |
20 | MP0003566_abnormal_cell_adhesion | 1.94789322 |
21 | MP0000685_abnormal_immune_system | 1.91885237 |
22 | MP0008961_abnormal_basal_metabolism | 1.85962881 |
23 | MP0002166_altered_tumor_susceptibility | 1.84774181 |
24 | MP0001835_abnormal_antigen_presentation | 1.79991145 |
25 | MP0005464_abnormal_platelet_physiology | 1.79397696 |
26 | MP0003191_abnormal_cellular_cholesterol | 1.79273867 |
27 | MP0001873_stomach_inflammation | 1.78697458 |
28 | MP0002877_abnormal_melanocyte_morpholog | 1.70317752 |
29 | MP0004264_abnormal_extraembryonic_tissu | 1.70254993 |
30 | MP0002148_abnormal_hypersensitivity_rea | 1.64612846 |
31 | MP0010155_abnormal_intestine_physiology | 1.61949546 |
32 | MP0001800_abnormal_humoral_immune | 1.59436384 |
33 | MP0010329_abnormal_lipoprotein_level | 1.59303038 |
34 | MP0001666_abnormal_nutrient_absorption | 1.57931148 |
35 | MP0003252_abnormal_bile_duct | 1.56816118 |
36 | MP0009278_abnormal_bone_marrow | 1.54130916 |
37 | MP0005387_immune_system_phenotype | 1.48963440 |
38 | MP0001790_abnormal_immune_system | 1.48963440 |
39 | MP0005083_abnormal_biliary_tract | 1.48243815 |
40 | MP0010307_abnormal_tumor_latency | 1.48203072 |
41 | MP0005000_abnormal_immune_tolerance | 1.43974396 |
42 | MP0002452_abnormal_antigen_presenting | 1.43032724 |
43 | MP0003866_abnormal_defecation | 1.40093939 |
44 | MP0001849_ear_inflammation | 1.39329955 |
45 | MP0000609_abnormal_liver_physiology | 1.38872833 |
46 | MP0002419_abnormal_innate_immunity | 1.35728174 |
47 | MP0005671_abnormal_response_to | 1.34832384 |
48 | MP0005023_abnormal_wound_healing | 1.32984775 |
49 | MP0000604_amyloidosis | 1.31001816 |
50 | MP0002420_abnormal_adaptive_immunity | 1.31000900 |
51 | MP0005409_darkened_coat_color | 1.30839774 |
52 | MP0001819_abnormal_immune_cell | 1.30655162 |
53 | MP0002723_abnormal_immune_serum | 1.30384783 |
54 | MP0002006_tumorigenesis | 1.29872348 |
55 | MP0005025_abnormal_response_to | 1.29641982 |
56 | MP0000465_gastrointestinal_hemorrhage | 1.29531269 |
57 | MP0002396_abnormal_hematopoietic_system | 1.29265937 |
58 | MP0002398_abnormal_bone_marrow | 1.28164629 |
59 | MP0005085_abnormal_gallbladder_physiolo | 1.27917304 |
60 | MP0006082_CNS_inflammation | 1.27834783 |
61 | MP0003329_amyloid_beta_deposits | 1.26329455 |
62 | MP0001845_abnormal_inflammatory_respons | 1.26094362 |
63 | MP0003763_abnormal_thymus_physiology | 1.26076523 |
64 | MP0005397_hematopoietic_system_phenotyp | 1.24352164 |
65 | MP0001545_abnormal_hematopoietic_system | 1.24352164 |
66 | MP0004185_abnormal_adipocyte_glucose | 1.23648808 |
67 | MP0004381_abnormal_hair_follicle | 1.20759851 |
68 | MP0004858_abnormal_nervous_system | 1.20077215 |
69 | MP0002405_respiratory_system_inflammati | 1.19274943 |
70 | MP0009785_altered_susceptibility_to | 1.14861061 |
71 | MP0004510_myositis | 1.14665902 |
72 | MP0000716_abnormal_immune_system | 1.14028160 |
73 | MP0003453_abnormal_keratinocyte_physiol | 1.13279929 |
74 | MP0001533_abnormal_skeleton_physiology | 1.13045084 |
75 | MP0003091_abnormal_cell_migration | 1.12394110 |
76 | MP0004808_abnormal_hematopoietic_stem | 1.08722845 |
77 | MP0002722_abnormal_immune_system | 1.08621121 |
78 | MP0003828_pulmonary_edema | 1.06818537 |
79 | MP0000689_abnormal_spleen_morphology | 1.06079210 |
80 | MP0003045_fibrosis | 1.05705481 |
81 | MP0005310_abnormal_salivary_gland | 1.05232582 |
82 | MP0002933_joint_inflammation | 1.03767601 |
83 | MP0003279_aneurysm | 1.01754858 |
84 | MP0006054_spinal_hemorrhage | 1.00302360 |
85 | MP0001851_eye_inflammation | 1.00096245 |
86 | MP0000858_altered_metastatic_potential | 0.99983924 |
87 | MP0009643_abnormal_urine_homeostasis | 0.98265095 |
88 | MP0002429_abnormal_blood_cell | 0.98237999 |
89 | MP0003690_abnormal_glial_cell | 0.97383249 |
90 | MP0003075_altered_response_to | 0.97317747 |
91 | MP0008469_abnormal_protein_level | 0.97306486 |
92 | MP0003448_altered_tumor_morphology | 0.96407038 |
93 | MP0008875_abnormal_xenobiotic_pharmacok | 0.95445348 |
94 | MP0002796_impaired_skin_barrier | 0.94641814 |
95 | MP0000003_abnormal_adipose_tissue | 0.93363677 |
96 | MP0008004_abnormal_stomach_pH | 0.92909067 |
97 | MP0000678_abnormal_parathyroid_gland | 0.92431739 |
98 | MP0001348_abnormal_lacrimal_gland | 0.91414939 |
99 | MP0000598_abnormal_liver_morphology | 0.90801588 |
100 | MP0000703_abnormal_thymus_morphology | 0.90185115 |
101 | MP0002998_abnormal_bone_remodeling | 0.90103669 |
102 | MP0009333_abnormal_splenocyte_physiolog | 0.89090657 |
103 | MP0001853_heart_inflammation | 0.88832397 |
104 | MP0002138_abnormal_hepatobiliary_system | 0.88780891 |
105 | MP0002136_abnormal_kidney_physiology | 0.88262062 |
106 | MP0005375_adipose_tissue_phenotype | 0.88229875 |
107 | MP0002118_abnormal_lipid_homeostasis | 0.88070283 |
108 | MP0001663_abnormal_digestive_system | 0.87575460 |
109 | MP0004130_abnormal_muscle_cell | 0.87442985 |
110 | MP0009764_decreased_sensitivity_to | 0.87411940 |
111 | MP0005166_decreased_susceptibility_to | 0.87397788 |
112 | MP0000490_abnormal_crypts_of | 0.85584496 |
113 | MP0001881_abnormal_mammary_gland | 0.84565381 |
114 | MP0009780_abnormal_chondrocyte_physiolo | 0.84444026 |
115 | MP0005390_skeleton_phenotype | 0.83813172 |
116 | MP0005319_abnormal_enzyme/_coenzyme | 0.82699803 |
117 | MP0000249_abnormal_blood_vessel | 0.81786217 |
118 | MP0005666_abnormal_adipose_tissue | 0.81350692 |
119 | MP0002254_reproductive_system_inflammat | 0.78930338 |
120 | MP0001958_emphysema | 0.77991606 |
121 | MP0000477_abnormal_intestine_morphology | 0.77817153 |
122 | MP0000371_diluted_coat_color | 0.77282867 |
123 | MP0003795_abnormal_bone_structure | 0.72701882 |
124 | MP0000343_altered_response_to | 0.69303767 |
125 | MP0008874_decreased_physiological_sensi | 0.68809355 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of macrophages (HP:0004311) | 3.50847726 |
2 | Cerebral aneurysm (HP:0004944) | 2.84747125 |
3 | Malnutrition (HP:0004395) | 2.68282815 |
4 | Mediastinal lymphadenopathy (HP:0100721) | 2.67807429 |
5 | Hand muscle atrophy (HP:0009130) | 2.67571736 |
6 | Eczematoid dermatitis (HP:0000976) | 2.67492520 |
7 | Obstructive sleep apnea (HP:0002870) | 2.63229515 |
8 | Increased cerebral lipofuscin (HP:0011813) | 2.60522385 |
9 | Broad face (HP:0000283) | 2.59879233 |
10 | Dysostosis multiplex (HP:0000943) | 2.59610385 |
11 | Orchitis (HP:0100796) | 2.54599250 |
12 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.53240647 |
13 | Mucopolysacchariduria (HP:0008155) | 2.53240647 |
14 | Obstructive lung disease (HP:0006536) | 2.51806095 |
15 | Chronic obstructive pulmonary disease (HP:0006510) | 2.51806095 |
16 | Myocardial infarction (HP:0001658) | 2.49535655 |
17 | Autoimmune thrombocytopenia (HP:0001973) | 2.49201336 |
18 | Spontaneous hematomas (HP:0007420) | 2.48860478 |
19 | Hemorrhage of the eye (HP:0011885) | 2.48235179 |
20 | Recurrent viral infections (HP:0004429) | 2.46722835 |
21 | Recurrent fungal infections (HP:0002841) | 2.44228932 |
22 | Meningitis (HP:0001287) | 2.41833290 |
23 | Upper limb amyotrophy (HP:0009129) | 2.41448783 |
24 | Distal upper limb amyotrophy (HP:0007149) | 2.41448783 |
25 | Pustule (HP:0200039) | 2.40790147 |
26 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.39924203 |
27 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.39924203 |
28 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.39924203 |
29 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.36989483 |
30 | Interstitial pulmonary disease (HP:0006530) | 2.33734297 |
31 | Colitis (HP:0002583) | 2.29949947 |
32 | Gastrointestinal stroma tumor (HP:0100723) | 2.29152457 |
33 | Periodontitis (HP:0000704) | 2.26040196 |
34 | Gastrointestinal infarctions (HP:0005244) | 2.25865219 |
35 | Macroorchidism (HP:0000053) | 2.25810587 |
36 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.25779585 |
37 | Aortic aneurysm (HP:0004942) | 2.24883583 |
38 | Hyperacusis (HP:0010780) | 2.21515122 |
39 | J-shaped sella turcica (HP:0002680) | 2.19589188 |
40 | Deep venous thrombosis (HP:0002625) | 2.19134676 |
41 | Recurrent bacterial skin infections (HP:0005406) | 2.18868741 |
42 | Emphysema (HP:0002097) | 2.18269899 |
43 | Gastrointestinal inflammation (HP:0004386) | 2.16810998 |
44 | Vasculitis (HP:0002633) | 2.16251619 |
45 | Flat acetabular roof (HP:0003180) | 2.12853743 |
46 | Aneurysm (HP:0002617) | 2.10748167 |
47 | Optic neuritis (HP:0100653) | 2.10584695 |
48 | Retrobulbar optic neuritis (HP:0100654) | 2.10584695 |
49 | Distal lower limb amyotrophy (HP:0008944) | 2.09569885 |
50 | Inflammation of the large intestine (HP:0002037) | 2.09350383 |
51 | Abnormality of the thoracic spine (HP:0100711) | 2.09180629 |
52 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.08481330 |
53 | Hematochezia (HP:0002573) | 2.08022106 |
54 | Neuronal loss in central nervous system (HP:0002529) | 2.07992350 |
55 | Xanthomatosis (HP:0000991) | 2.06401093 |
56 | Polygenic inheritance (HP:0010982) | 2.05941012 |
57 | Recurrent abscess formation (HP:0002722) | 2.02881498 |
58 | Abnormality of the fingertips (HP:0001211) | 2.01449454 |
59 | Slow saccadic eye movements (HP:0000514) | 2.00787693 |
60 | T lymphocytopenia (HP:0005403) | 1.99786847 |
61 | Spastic diplegia (HP:0001264) | 1.99515053 |
62 | Prolonged bleeding time (HP:0003010) | 1.98776794 |
63 | Long toe (HP:0010511) | 1.93967891 |
64 | Purpura (HP:0000979) | 1.93800632 |
65 | Systemic lupus erythematosus (HP:0002725) | 1.93776444 |
66 | Restrictive lung disease (HP:0002091) | 1.92887221 |
67 | Esophageal varix (HP:0002040) | 1.92133968 |
68 | Complement deficiency (HP:0004431) | 1.91667514 |
69 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.91408841 |
70 | Impaired platelet aggregation (HP:0003540) | 1.89862641 |
71 | Abnormal platelet function (HP:0011869) | 1.89862641 |
72 | Dilatation of the ascending aorta (HP:0005111) | 1.89354207 |
73 | Thoracic kyphosis (HP:0002942) | 1.89222214 |
74 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.89206266 |
75 | Increased CSF protein (HP:0002922) | 1.89176171 |
76 | Epistaxis (HP:0000421) | 1.88648934 |
77 | Hemoptysis (HP:0002105) | 1.88582795 |
78 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.87269034 |
79 | Abnormal platelet volume (HP:0011876) | 1.86256846 |
80 | Neurofibrillary tangles (HP:0002185) | 1.86239575 |
81 | Urticaria (HP:0001025) | 1.85914492 |
82 | Subacute progressive viral hepatitis (HP:0006572) | 1.85730059 |
83 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.85711094 |
84 | Nasal polyposis (HP:0100582) | 1.85575810 |
85 | Osteomyelitis (HP:0002754) | 1.85412934 |
86 | Gingivitis (HP:0000230) | 1.85139202 |
87 | Severe short stature (HP:0003510) | 1.84759290 |
88 | Abnormality of T cell number (HP:0011839) | 1.84654202 |
89 | Cellulitis (HP:0100658) | 1.84403471 |
90 | Mitral stenosis (HP:0001718) | 1.84391754 |
91 | Mitral valve prolapse (HP:0001634) | 1.83871933 |
92 | Polycythemia (HP:0001901) | 1.83792911 |
93 | Increased density of long bones (HP:0006392) | 1.83695434 |
94 | Cervical subluxation (HP:0003308) | 1.82894787 |
95 | Axonal loss (HP:0003447) | 1.82490916 |
96 | Amyloidosis (HP:0011034) | 1.81826447 |
97 | Loss of speech (HP:0002371) | 1.81747255 |
98 | Heterotopia (HP:0002282) | 1.81464200 |
99 | Increased mean platelet volume (HP:0011877) | 1.81218971 |
100 | Pulmonary infiltrates (HP:0002113) | 1.81028154 |
101 | Vacuolated lymphocytes (HP:0001922) | 1.81021178 |
102 | Frequent falls (HP:0002359) | 1.80918409 |
103 | Gingival bleeding (HP:0000225) | 1.79898489 |
104 | Chronic otitis media (HP:0000389) | 1.79711840 |
105 | Increased connective tissue (HP:0009025) | 1.79405418 |
106 | Striae distensae (HP:0001065) | 1.78510376 |
107 | Fatigue (HP:0012378) | 1.77904387 |
108 | Distal lower limb muscle weakness (HP:0009053) | 1.77783913 |
109 | Premature loss of primary teeth (HP:0006323) | 1.77126350 |
110 | Agammaglobulinemia (HP:0004432) | 1.76582924 |
111 | Radial bowing (HP:0002986) | 1.76443258 |
112 | Glomerulonephritis (HP:0000099) | 1.76102691 |
113 | Increased serum ferritin (HP:0003281) | 1.75950184 |
114 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.75018299 |
115 | Bone pain (HP:0002653) | 1.74906524 |
116 | Chest pain (HP:0100749) | 1.73865072 |
117 | Supranuclear gaze palsy (HP:0000605) | 1.73600641 |
118 | Osteolytic defects of the hand bones (HP:0009699) | 1.73469477 |
119 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.73469477 |
120 | Verrucae (HP:0200043) | 1.73236381 |
121 | Papilloma (HP:0012740) | 1.73236381 |
122 | Vertebral compression fractures (HP:0002953) | 1.72875380 |
123 | Arterial thrombosis (HP:0004420) | 1.72694064 |
124 | Abnormality of the common coagulation pathway (HP:0010990) | 1.71102977 |
125 | Thin bony cortex (HP:0002753) | 1.70586266 |
126 | Abnormality of complement system (HP:0005339) | 1.70517170 |
127 | Cerebral inclusion bodies (HP:0100314) | 1.70473945 |
128 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.70304512 |
129 | Petechiae (HP:0000967) | 1.69915574 |
130 | Global brain atrophy (HP:0002283) | 1.69434943 |
131 | Increased IgE level (HP:0003212) | 1.68868962 |
132 | Coarse hair (HP:0002208) | 1.68438226 |
133 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.67387100 |
134 | Abnormality of oral frenula (HP:0000190) | 1.66778454 |
135 | Abnormality of the nasal mucosa (HP:0000433) | 1.66702110 |
136 | Disproportionate tall stature (HP:0001519) | 1.66120895 |
137 | Pseudobulbar signs (HP:0002200) | 1.65880939 |
138 | Abnormality of glycolipid metabolism (HP:0010969) | 1.65674942 |
139 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.65674942 |
140 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.65674942 |
141 | Recurrent skin infections (HP:0001581) | 1.64847604 |
142 | Enlarged penis (HP:0000040) | 1.64519910 |
143 | Upper motor neuron abnormality (HP:0002127) | 1.63844851 |
144 | Abnormality of the lower motor neuron (HP:0002366) | 1.63833376 |
145 | Ulnar bowing (HP:0003031) | 1.63312308 |
146 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.60386100 |
147 | Recurrent cutaneous fungal infections (HP:0011370) | 1.60386100 |
148 | Abdominal distention (HP:0003270) | 1.56956052 |
149 | Thrombocytosis (HP:0001894) | 1.56619252 |
150 | Micronodular cirrhosis (HP:0001413) | 1.54893825 |
151 | Myositis (HP:0100614) | 1.54842387 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TRIB3 | 3.75894565 |
2 | ERN1 | 3.70453307 |
3 | PRPF4B | 3.23637329 |
4 | PKN2 | 3.13562651 |
5 | MAP4K1 | 2.75036591 |
6 | EEF2K | 2.69719729 |
7 | CDK12 | 2.53336016 |
8 | SMG1 | 2.42598158 |
9 | MAP3K10 | 2.41651927 |
10 | SIK1 | 2.18692029 |
11 | PTK6 | 2.06958194 |
12 | IRAK3 | 2.04022420 |
13 | FGFR4 | 1.92604019 |
14 | SCYL2 | 1.90550135 |
15 | ZAP70 | 1.77403337 |
16 | STK10 | 1.76318245 |
17 | TYK2 | 1.75978921 |
18 | RIPK1 | 1.72309569 |
19 | TAOK3 | 1.68196882 |
20 | CAMK1D | 1.62465936 |
21 | JAK1 | 1.54300629 |
22 | JAK3 | 1.50610011 |
23 | GRK6 | 1.48795334 |
24 | LRRK2 | 1.46321563 |
25 | TBK1 | 1.45193359 |
26 | CDC42BPA | 1.43120414 |
27 | MARK2 | 1.40865592 |
28 | SIK2 | 1.37824007 |
29 | EPHB1 | 1.36623257 |
30 | CAMK1G | 1.32005534 |
31 | PDGFRA | 1.31717494 |
32 | CDK6 | 1.30623009 |
33 | ITK | 1.28579221 |
34 | TNK2 | 1.27628519 |
35 | FES | 1.23479813 |
36 | FGFR3 | 1.22555673 |
37 | PRKD2 | 1.16720314 |
38 | TAOK1 | 1.15773949 |
39 | TTN | 1.14087735 |
40 | MAP2K3 | 1.13583202 |
41 | RIPK4 | 1.11904779 |
42 | BMX | 1.11222238 |
43 | TAOK2 | 1.11045707 |
44 | HCK | 1.06568940 |
45 | CAMKK1 | 1.05877654 |
46 | JAK2 | 1.05588487 |
47 | MAP3K13 | 1.03808578 |
48 | ALK | 1.00592173 |
49 | PTK2 | 0.99399421 |
50 | BTK | 0.98546142 |
51 | KSR2 | 0.96706218 |
52 | PAK4 | 0.94588912 |
53 | CSK | 0.93416443 |
54 | PDGFRB | 0.93344070 |
55 | TGFBR2 | 0.92980915 |
56 | CSF1R | 0.89518151 |
57 | MTOR | 0.89061638 |
58 | ICK | 0.88356040 |
59 | FRK | 0.87898898 |
60 | RET | 0.87244291 |
61 | IKBKE | 0.85638038 |
62 | TESK2 | 0.85562662 |
63 | BLK | 0.82064486 |
64 | FLT3 | 0.81393984 |
65 | FGR | 0.79399005 |
66 | CHUK | 0.79322031 |
67 | RPS6KL1 | 0.78932947 |
68 | RPS6KC1 | 0.78932947 |
69 | MAP3K6 | 0.77778916 |
70 | PRKCH | 0.76089070 |
71 | SIK3 | 0.74142154 |
72 | MAP3K14 | 0.73794031 |
73 | KIT | 0.73712135 |
74 | MAP3K7 | 0.73016942 |
75 | CDK4 | 0.72794484 |
76 | RPS6KB2 | 0.72589415 |
77 | MAP3K9 | 0.72543333 |
78 | EPHA2 | 0.70537242 |
79 | SYK | 0.69607691 |
80 | NME2 | 0.68620538 |
81 | LCK | 0.66266690 |
82 | MAP2K2 | 0.66119477 |
83 | MARK3 | 0.64723569 |
84 | DYRK1B | 0.64670293 |
85 | MAP3K2 | 0.64606445 |
86 | MAP3K8 | 0.64424381 |
87 | TESK1 | 0.64245029 |
88 | RPS6KA4 | 0.64076094 |
89 | PAK2 | 0.62721941 |
90 | SGK3 | 0.62156362 |
91 | CDK9 | 0.61160610 |
92 | RPS6KA6 | 0.60851027 |
93 | MAP3K3 | 0.59307331 |
94 | MATK | 0.59141205 |
95 | PDK1 | 0.58788323 |
96 | MAPK12 | 0.58666173 |
97 | DDR2 | 0.58048959 |
98 | PIM1 | 0.57837553 |
99 | FGFR1 | 0.57735306 |
100 | TYRO3 | 0.57265862 |
101 | MAPK7 | 0.57211585 |
102 | LYN | 0.56811398 |
103 | TXK | 0.55832456 |
104 | PASK | 0.55775310 |
105 | MAPKAPK3 | 0.55741758 |
106 | MAP3K1 | 0.55357633 |
107 | IRAK2 | 0.54258877 |
108 | LATS1 | 0.53524288 |
109 | EGFR | 0.52211413 |
110 | NEK2 | 0.50237625 |
111 | STK38 | 0.50018303 |
112 | MAPK11 | 0.49749366 |
113 | PRKG2 | 0.48834336 |
114 | ERBB2 | 0.48437070 |
115 | BRD4 | 0.47718605 |
116 | PDPK1 | 0.47224506 |
117 | HIPK2 | 0.46909552 |
118 | MAP3K11 | 0.46404188 |
119 | MAP2K6 | 0.44843166 |
120 | LMTK2 | 0.43478269 |
121 | DAPK2 | 0.42541573 |
122 | IKBKB | 0.42460066 |
123 | STK3 | 0.39661273 |
124 | RPS6KA2 | 0.39637832 |
125 | FYN | 0.38976095 |
126 | IRAK4 | 0.38722735 |
127 | MST1R | 0.38374663 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.55175119 |
2 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.67654399 |
3 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.62000258 |
4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.61049935 |
5 | Allograft rejection_Homo sapiens_hsa05330 | 1.60349166 |
6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.57590771 |
7 | Leishmaniasis_Homo sapiens_hsa05140 | 1.57258773 |
8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.57239953 |
9 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.48397905 |
10 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.47526374 |
11 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.46518971 |
12 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.45056644 |
13 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.44679803 |
14 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.39697683 |
15 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.36081160 |
16 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.30992206 |
17 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.28586912 |
18 | Lysine degradation_Homo sapiens_hsa00310 | 1.27981409 |
19 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.22591481 |
20 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.22026588 |
21 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.21863006 |
22 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.21778505 |
23 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.20197842 |
24 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.19984681 |
25 | Insulin resistance_Homo sapiens_hsa04931 | 1.19609345 |
26 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.18990153 |
27 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.18843579 |
28 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.17633467 |
29 | Lysosome_Homo sapiens_hsa04142 | 1.17611802 |
30 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.16144424 |
31 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.15352107 |
32 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.15046049 |
33 | Bile secretion_Homo sapiens_hsa04976 | 1.13877498 |
34 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.11561523 |
35 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.10628002 |
36 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.10123570 |
37 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.09284608 |
38 | Measles_Homo sapiens_hsa05162 | 1.08469562 |
39 | Asthma_Homo sapiens_hsa05310 | 1.04457055 |
40 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.04267047 |
41 | Malaria_Homo sapiens_hsa05144 | 1.04144278 |
42 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.03962458 |
43 | Tuberculosis_Homo sapiens_hsa05152 | 1.03184956 |
44 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.02087785 |
45 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.01514549 |
46 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.00456006 |
47 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.00157915 |
48 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.00078141 |
49 | Shigellosis_Homo sapiens_hsa05131 | 0.98141723 |
50 | Influenza A_Homo sapiens_hsa05164 | 0.97676153 |
51 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.96736220 |
52 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.94062993 |
53 | Apoptosis_Homo sapiens_hsa04210 | 0.93375022 |
54 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.92977395 |
55 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.92517397 |
56 | Prion diseases_Homo sapiens_hsa05020 | 0.90839588 |
57 | Hepatitis B_Homo sapiens_hsa05161 | 0.89637637 |
58 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.89305106 |
59 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.88627520 |
60 | Endometrial cancer_Homo sapiens_hsa05213 | 0.88138553 |
61 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.87803538 |
62 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.87473252 |
63 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.87216822 |
64 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.85923908 |
65 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.85824874 |
66 | ABC transporters_Homo sapiens_hsa02010 | 0.85821011 |
67 | Platelet activation_Homo sapiens_hsa04611 | 0.85432304 |
68 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.85220304 |
69 | Glioma_Homo sapiens_hsa05214 | 0.85128973 |
70 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.85117919 |
71 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.84681146 |
72 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.84250269 |
73 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.83511400 |
74 | Hepatitis C_Homo sapiens_hsa05160 | 0.83013469 |
75 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.81630762 |
76 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.81356484 |
77 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.81062218 |
78 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.80207146 |
79 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.79897943 |
80 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.79500366 |
81 | Amoebiasis_Homo sapiens_hsa05146 | 0.79232377 |
82 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.78260211 |
83 | Phagosome_Homo sapiens_hsa04145 | 0.78075610 |
84 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.77788030 |
85 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.76423300 |
86 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.76349630 |
87 | Bladder cancer_Homo sapiens_hsa05219 | 0.76337911 |
88 | Legionellosis_Homo sapiens_hsa05134 | 0.75554117 |
89 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.74122681 |
90 | Pertussis_Homo sapiens_hsa05133 | 0.71513186 |
91 | Endocytosis_Homo sapiens_hsa04144 | 0.69823752 |
92 | Adherens junction_Homo sapiens_hsa04520 | 0.69786659 |
93 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.69651338 |
94 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.69072880 |
95 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.68515132 |
96 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.67513903 |
97 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.66831865 |
98 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.66814054 |
99 | Salmonella infection_Homo sapiens_hsa05132 | 0.66218755 |
100 | Focal adhesion_Homo sapiens_hsa04510 | 0.63565305 |
101 | Other glycan degradation_Homo sapiens_hsa00511 | 0.63561074 |
102 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.63528112 |
103 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.63206722 |
104 | HTLV-I infection_Homo sapiens_hsa05166 | 0.62436600 |
105 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.61849167 |
106 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.61784882 |
107 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.61647013 |
108 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.61600057 |
109 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.60959618 |
110 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.60557070 |
111 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.60401667 |
112 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.60188414 |
113 | Viral myocarditis_Homo sapiens_hsa05416 | 0.59647931 |
114 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.58590060 |
115 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.58354933 |
116 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.57774729 |
117 | Colorectal cancer_Homo sapiens_hsa05210 | 0.57773230 |
118 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.57744210 |
119 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.57737897 |
120 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.57593247 |
121 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.57243065 |
122 | Galactose metabolism_Homo sapiens_hsa00052 | 0.56803056 |
123 | Prostate cancer_Homo sapiens_hsa05215 | 0.56291967 |
124 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.55991186 |
125 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.53004913 |
126 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.52782112 |
127 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.52420610 |
128 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.52199486 |
129 | Thyroid cancer_Homo sapiens_hsa05216 | 0.51075312 |
130 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.50747897 |
131 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.49256887 |